Lucid Diagnostics, Inc. (LUCD)
0.6029
+0.01
(+1.62%)
USD |
NASDAQ |
Oct 06, 16:00
0.6101
+0.01
(+1.19%)
After-Hours: 19:37
Lucid Diagnostics Cash from Investing (Quarterly) : -0.021M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.021M |
| March 31, 2026 | -0.215M |
| December 31, 2025 | -0.051M |
| September 30, 2025 | -0.028M |
| June 30, 2025 | -0.025M |
| March 31, 2025 | -0.093M |
| December 31, 2024 | -0.259M |
| September 30, 2024 | -0.35M |
| June 30, 2024 | 0.00 |
| March 31, 2024 | -0.037M |
| December 31, 2023 | -0.175M |
| September 30, 2023 | -0.014M |
| June 30, 2023 | -0.015M |
| Date | Value |
|---|---|
| March 31, 2023 | -0.017M |
| December 31, 2022 | -0.203M |
| September 30, 2022 | -1.321M |
| June 30, 2022 | -2.436M |
| March 31, 2022 | -0.148M |
| December 31, 2021 | -0.8241M |
| September 30, 2021 | -0.0276M |
| June 30, 2021 | -0.0008M |
| March 31, 2021 | -0.0095M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| IDEXX Laboratories, Inc. | -25.50M |
| Neogen Corp. | -4.00M |
| QuidelOrtho Corp. | -107.30M |
| Aspira Women's Health, Inc. | -0.15M |
| VolitionRX Ltd. | -0.0016M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -11.30M |
| Cash from Financing (Quarterly) | 16.85M |
| Free Cash Flow | -47.18M |
| Free Cash Flow Per Share (Quarterly) | -0.0618 |
| Free Cash Flow to Equity (Quarterly) | -9.424M |
| Free Cash Flow to Firm (Quarterly) | -11.31M |
| Free Cash Flow Yield | -55.65% |